Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Abilify generic cost?Latuda without insurance?Lokelma 10 mg cost in india?Is levothyroxine expensive?Lactulose ingredients?
See the DrugPatentWatch profile for prolia
What is Prolia and its Generic Equivalents? Prolia, with the active ingredient denosumab, is a prescription medication used to treat osteoporosis in postmenopausal women at high risk for fracture, men at high risk for fracture, and adults with bone loss due to certain cancer treatments [1]. It is also used to treat giant cell tumor of bone that is unresectable or where surgical resection is likely to result in severe morbidity [1]. Prolia works by inhibiting osteoclast activity, which reduces bone breakdown [2]. As of now, there are no approved generic versions of Prolia available in the United States [3]. The drug is manufactured by Amgen [1]. When Can Generic Versions of Prolia Be Expected? The availability of generic drugs typically follows the expiration of patents and other market exclusivities held by the innovator company. Patent information for drugs can be complex, often involving multiple patents covering different aspects of the drug, such as its composition, method of use, and manufacturing process [4]. Companies that develop generic versions of a drug must navigate these patent landscapes. Often, generic manufacturers will challenge existing patents or wait for them to expire before launching their products [4]. Information regarding the patent status and potential for generic entry for specific drugs can be found on resources like DrugPatentWatch.com [5]. How Does Prolia Work? Prolia is a human monoclonal antibody that targets RANK ligand (RANKL) [2]. RANKL is a protein that plays a critical role in the formation, function, and survival of osteoclasts, the cells responsible for bone resorption (breakdown) [2]. By binding to RANKL, denosumab prevents it from interacting with its receptor, RANK, on the surface of osteoclast precursors and mature osteoclasts [2]. This inhibition ultimately reduces osteoclast activity and bone resorption, leading to increased bone mineral density and a reduced risk of fractures [2]. What Are the Risks Associated with Prolia? Like all medications, Prolia carries potential risks and side effects. Common side effects include pain in the extremities, muscle spasms, and urinary tract infections [1]. More serious but less common side effects can include hypocalcemia (low calcium levels), severe allergic reactions, osteonecrosis of the jaw, and atypical femur fractures [1]. Patients should discuss their medical history and any concerns with their healthcare provider before starting Prolia [1]. Sources 1. https://www.prolia.com/ 2. https://www.drugbank.ca/drugs/DB01405 3. Food and Drug Administration (FDA) generic drug approval databases. (Information based on current availability as of [insert current date or state that information is based on available data]). 4. https://www.drugpatentwatch.com/ 5. https://www.drugpatentwatch.com/
Other Questions About Prolia :